Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 AUD | -6.67% | +18.31% | +21.74% |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
Apr. 24 | Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 348M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.70% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
+27.16% | 12.05B | |
-3.63% | 11.7B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Receives Scientific Advice for Clinical Development of Cancer Drug